F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians 2024; 74(3): 229-63.

A.C. Celsus, W. Spencer. De medicina. London: W. 1935, Heinemann ltd. 1935; :

R.A. Willis. The spread of tumours in the human body. J. & A. Churchill 1934; :

G. Hadfield. The dormant cancer cell. BMJ (Clinical Research Ed.) 1954; 2(4888): 607-10.

M.A. Gimbrone, S.B. Leapman, R.S. Cotran, J. Folkman. Tumor dormancy in vivo by prevention of neovascularization. The Journal of Experimental Medicine 1972; 136(2): 261-76.

X. Wang, J. Yu, J. Yan, K. Peng, H. Zhou. Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy. BMC Urology 2022; 22(1): 37.

M.O. Laguillaumie, S. Titah, A. Guillemette, B. Neve, F. Leprêtre, P. Ségard. Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia. Biological Research 2024; 57(1): 59.

H. David. Rudolf Virchow and modern aspects of tumor pathology. Pathology, Research and Practice 1988; 183(3): 356-64.

J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1(1): 27-30.

J.A. Aguirre-Ghiso. Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews. Cancer 2007; 7(11): 834-46.

A.C. Yeh, S. Ramaswamy. Mechanisms of cancer cell dormancy\textemdashanother hallmark of cancer?. Cancer Research 2015; 75(23): 5014-22.

H. Endo, M. Inoue. Dormancy in cancer. Cancer Science 2019; 110(2): 474-80.

M.S. Ganesh, R. Revanth, C.M. Bharathi. Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence. Journal of Cancer Research Updates 2025; 14: 1-11.

M. Retsky, R. Demicheli, W.J. Hrushesky. Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. International Journal of Surgery 2005; 3(3): 179-87.

J. Dittmer. The Mechanism Enabling Hibernation in Mammals. In: Iwaya-Inoue, M., Sakurai, M., Uemura, M. (eds) Survival Strategies in Extreme Cold and Desiccation. Advances in Experimental Medicine and Biology 2017; 1081:

Y. Horii, T. Shiina, Y. Shimizu. ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK. Cancer research 2018; 63(7): 1684-95.

J.A. Aguirre-Ghiso. ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK. Cancer Research 2003; 63(7): 1684-95.

Y. Fan, X. Ren, Y. Wang, E. Xu, S. Wang, R. Ge. Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway in vitro. Oncology Letters 2021; 22(6): 1-7.

I. Herr, K.M. Debatin. Cellular stress response and apoptosis in cancer therapy. Blood 2001; 98(9): 2603-14.

M.H. Manjili. Tumor dormancy and relapse: from a natural byproduct of evolution to a disease state. Cancer Research 2017; 77(10): 2564-9.

H. Shimizu, S. Takeishi, H. Nakatsumi, K.I. Nakayama. Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells. JCI Insight 2019; 4(4): e125138.

C. Prunier, D. Baker, P. ten Dijke, L. Ritsma. TGF-β family signaling pathways in cellular dormancy. Trends in Cancer 2019; 5(1): 66-78.

M.S. Sosa, F. Parikh, A.G. Maia, Y. Estrada, A. Bosch, P. Bragado. NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes. Nature Communications 2015; 6(1): 6170.

P. Bragado, Y. Estrada, F. Parikh, S. Krause, C. Capobianco, H.G. Farina. TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. Nature Cell Biology 2013; 15(11): 1351-61.

A. Kobayashi, H. Okuda, F. Xing, P.R. Pandey, M. Watabe, S. Hirota. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. The Journal of Experimental Medicine 2011; 208(13): 2641-55.

J.T. Buijs, C.A. Rentsch, G. van der Horst, P.G. van Overveld, A. Wetterwald, R. Schwaninger. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. The American Journal of Pathology 2007; 171(3): 1047-57.

A.R. Nobre, E. Risson, D.K. Singh, J.S. Di Martino, J.F. Cheung, J. Wang. Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-β2. Nature Cancer 2021; 2(3): 327-39.